Celgard Successful in UK Court and is Granted Injunction Against Senior Battery Separator Imports Through Trial

CHARLOTTE, N.C., Aug. 6, 2020 /PRNewswire/ — Following the United Kingdom (UK) court’s grant on May 7, 2020 of an interim injunction against Shenzhen Senior Technology Material Co., Ltd. (Senior) as requested by Celgard, LLC (Celgard), a subsidiary of Polypore International, LP (Polypore), and the UK court’s May 21, 2020 order continuing the effect of the interim injunction, the UK court issued a Judgement on July 30, 2020 granting an injunction through trial and…

CHARLOTTE, N.C., Aug. 6, 2020 /PRNewswire/ — Following the United Kingdom (UK) court’s grant on May 7, 2020 of an interim injunction against Shenzhen Senior Technology Material Co., Ltd. (Senior) as requested by Celgard, LLC (Celgard), a subsidiary of Polypore International, LP (Polypore), and the UK court’s May 21, 2020 order continuing the effect of the interim injunction, the UK court issued a Judgement on July 30, 2020 granting an injunction through trial and will make an order in the terms sought by Celgard that blocks Senior’s import of Battery Separators into the UK through trial. 

The court’s Judgement in favor of Celgard not only granted the injunction against Senior, it also held that Celgard had established a serious issue to be tried that Senior had used its trade secrets in developing and manufacturing battery separators and that England was the proper forum for the importation dispute. Celgard intends to fully pursue its trade secret case against Senior.

On April 30, 2020, Celgard filed an application for an urgent injunction against Senior in the High Court of Justice in London, England. On May 7, on an ex parte basis, the UK court granted an interim injunction to prevent Senior from importing certain battery separators into the UK.

Earlier, on March 2, Celgard filed a Complaint against Defendants Shenzhen Senior Technology Material Co. Ltd. (Senior-China), Shenzhen Senior Technology Material Co. Ltd. (US) Research Institute (Senior-California), Xiaomin (Steven) Zhang, Sun Town Technology, Inc., Global Venture Development, LLC, and Global Venture Development, Inc. (collectively, Global Venture) (collectively, WDNC Defendants) in the U.S. District Court for the Western District of North Carolina (WDNC) for trade secret misappropriation, unfair and deceptive trade practices and unfair competition, civil conspiracy, unjust enrichment and conversion.

Additionally, Celgard filed a Second Amended Complaint against Defendants including Shenzhen Senior Technology Material Co. Ltd. (US) Research Institute (Senior-California) and others (collectively, NDCA Defendants) for patent infringement, breach of contract and breach of implied covenant of good faith and fair dealing in the U.S. District Court for the Northern District of California (NDCA). 

The WDNC Complaint alleges the WDNC Defendants, including a former Celgard employee, Xiaomin (Steven) Zhang, now CTO of Senior-China who changed his name to Bin Wang at the request of Senior-China, purposely and unlawfully misappropriated Celgard’s trade secrets and confidential information and continue to do so. Several other violations of the law are also alleged. 

The NDCA Second Amended Complaint alleges the NDCA Defendants infringe Celgard’s United States Reissued Patent RE47,520 (the ‘520 patent), formerly United States Patent 6,432,586 (the ‘586 patent), and Celgard’s United States Patent No. 6,692,867 (the ‘867 patent). See Release.

In December 2019, Celgard filed a First Amended Complaint in the NDCA adding to the suit the Defendants Farasis,Sun Town, and Global Venture. See Release. 

In September 2019, Celgard filed suit against Senior who sells separators globally that they make in Shenzhen, China. Celgard’s Complaint alleged Senior had infringed Celgard’s U.S. ‘520 and ‘867 patents, and has unlawfully misappropriated and misused Celgard’s trade secrets and confidential information, among other violations and seeks compensation for damages. See Release.

In September 2019, Celgard successfully settled a patent infringement lawsuit against Targray International. See Release. Celgard also successfully settled two suits in June 2019, against MTI Corporation. See Release.

The UK Judgement and the successful outcome of the Targray and MTI cases further solidifies the integrity of Celgard’s intellectual property (IP) regarding coated and uncoated separators for lithium-ion batteries. Celgard will continue to prevent the unfair exploitation of its technology and IP to safeguard its assets and customers.

About Celgard and Polypore

Celgard specializes in coated and uncoated dry-process microporous membranes used as separators that are a major component of lithium-ion batteries. Celgard’s battery separator technology is important to the performance of lithium-ion batteries for electric drive vehicles, energy storage systems and other applications.

Celgard, LLC is a wholly-owned subsidiary of Polypore International, LP, an Asahi Kasei Company.

Polypore is a global company with facilities in nine countries specializing in microporous membranes used in electric and nonelectric vehicles, energy storage systems and specialty applications. Visit www.celgard.com and www.polypore.com.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/celgard-successful-in-uk-court-and-is-granted-injunction-against-senior-battery-separator-imports-through-trial-301107279.html

SOURCE Polypore International, LP

Acetic Acid Market Size, Share & Trends Analysis Report By Application, By Region And Segment Forecasts, 2020 – 2027

NEW YORK, Aug. 6, 2020 /PRNewswire/ —

Read the full report: https://www.reportlinker.com/p05949297/?utm_source=PRN

Acetic Acid Market Growth & Trends

The global acetic acid market size is…

NEW YORK, Aug. 6, 2020 /PRNewswire/ —

Read the full report: https://www.reportlinker.com/p05949297/?utm_source=PRN

Acetic Acid Market Growth & Trends

The global acetic acid market size is projected to reach USD 13.41 billion by 2027. The market is projected to expand at a CAGR of 5.2% in terms of revenue, from 2020 to 2027. High demand for Vinyl Acetate Monomer (VAM) from various end-use industries such as textiles, adhesives, and coatings and paint industries worldwide is a major factor driving the industry growth.

VAM is the largest application market of acetic acid.Growing construction activities globally has resulted in a high requirement for VAM.

Vinyl acetate monomer is largely used in manufacturing paints and coatings, wherein the majority of the same goes into construction activities. Considering the recent virus outbreak, multiple healthcare facilities have been built across Asian countries such as China and India, the U.S., and Canada in North America, and across Europe. This exponentially increased construction activities and eventually led to a high requirement for VAM, thereby reflecting the high demand for acetic acid globally.

Another key point of application of the chemical is in formulating Purified Terephthalic Acid (PTA) which is broadly utilized to produce polyester coating resins.These are widely used in an array of end-use industries such as coil coatings, automotive, appliances, and more.

Further, the demand for polyester fiber produced from PTA is increasing due to the increasing requirement of the product to produce fabrics for home furnishings and apparel.

However, the substance is closely monitored by multiple regulatory authorities such as the U.S. EPA, OCHA, REACH, and more. Acetic acid is a hazardous chemical that is harmful to aquatic organisms if disposed of untreated, it’s a flammable vapor and liquid, and it also causes eye damage and severe skin burn if stayed in exposed to higher than permissible limits. Regulatory bodies have mandated the use of personal protective equipment while handling the chemical to prevent any hazard caused due to the corrosive nature of the substance.

China was the key producer of the chemical, followed by the U.S. and Western Europe. However, the production and consumption scenarios are likely to change due to the recent global outbreak of the coronavirus. Middle East is projected to have multiple capacity additions by 2022 on accounts of the growing demand of the product from the construction industry as well as the food and beverage processing sector across UAE and Saudi Arabia.

Acetic Acid Market Report Highlights
• Vinyl acetate monomer application is expected to witness a CAGR of 4.1%, in terms of volume, from 2020 to 2027 due to increasing demand for the product from paints, coatings, and adhesives sector
• Ethanol application is expected to witness a CAGR of 7.8%, in terms of volume, from 2020 to 2027 due to the product’s increasing consumption as a solvent from healthcare industries globally for disinfectant product formulations
Asia Pacific is expected to register the fastest CAGR of 5.0%, in terms of volume, from 2020 to 2027 owing to increasing penetration of polymer and resin producers in China, India, Vietnam, and Indonesia to cater paints, textiles, coatings, and films industries
• Celanese Corporation and British Petroleum are the largest manufacturers of acetic acid worldwide and are also recorded as key innovators from a product development standpoint
• The industry is concentrated with multiple international brands with presence across all major economies, thereby restricting new entrants into the ecosystem

Read the full report: https://www.reportlinker.com/p05949297/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________
Contact Clare: clare@reportlinker.com  
US: (339)-368-6001
Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/acetic-acid-market-size-share–trends-analysis-report-by-application-by-region-and-segment-forecasts-2020—2027-301107413.html

SOURCE Reportlinker

Aethlon Medical Announces Collaboration with University of Pittsburgh on NIH Grant for Head and Neck Cancer

SAN DIEGO, Aug. 6, 2020 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device and technology company focused on unmet needs in oncology and viral diseases announced today that the National Institute for Dental and Craniofacial Research (NIDCR), a unit of the National Institutes for Health (NIH), has awarded a grant for studies in head and neck cancer that will be a collaborative project between Aethlon and the UPMC Hillman Cancer Center at the

SAN DIEGO, Aug. 6, 2020 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device and technology company focused on unmet needs in oncology and viral diseases announced today that the National Institute for Dental and Craniofacial Research (NIDCR), a unit of the National Institutes for Health (NIH), has awarded a grant for studies in head and neck cancer that will be a collaborative project between Aethlon and the UPMC Hillman Cancer Center at the University of Pittsburgh.

The grant, entitled «Depleting exosomes to improve responses to immune therapy in head and neck squamous cell carcinoma« will profile the biomarkers of exosomes in patients with recurrent and metastatic head and neck cancer and will explore the impact of clinical depletion of exosomes using Aethlon’s proprietary Hemopurifier device. Exosomes are nanosized particles that are released in large quantities from cancer cells and carry the complement of a tumor’s genetic and protein cargo, which endows them with the capacity to fuel cancer growth and immune suppression. The Hemopurifier is being advanced as a potential therapeutic device for oncology by virtue of its capacity to capture and remove exosomes from plasma.

The total value of the award is $3.5 million over five years for multi-institution studies that will be led by Drs. Theresa Whiteside at UPMC and Annette Marleau at Aethlon as Principal Investigators. The funds will be primarily allocated to UPMC and two other participating academic institutions that will apply their expertise in immuno-oncology to programs that could accelerate the clinical advancement of the Hemopurifier.

«We are delighted to have the opportunity to work with Dr. Whiteside, a leading researcher in the area of tumor-derived exosomes, and the multidisciplinary team that has been assembled to evaluate the effects of exosomes in head and neck cancer,» stated Timothy C. Rodell, M.D., CEO of Aethlon Medical. «Head and neck cancer continues to have a poor prognosis due to disease recurrence and the development of metastatic disease.  We believe that the real value of this grant for Aethlon is that this work will provide insights into the potential clinical benefits of depleting circulating exosomes using the Hemopurifier for improving the responses of patients to the standard immunotherapy treatments.»

 «We are appreciative of the funding from NIDCR for this investigation of the roles of exosomes in head and neck cancer,» stated Theresa Whiteside, Ph.D., Principal Investigator and Professor of Pathology, Immunology and Otolaryngology at UPMC. «Exosomes have emerged as major contributors to tumor-associated immune suppression and as significant barriers to cancer therapies. The overarching objective of this work will be to advance therapeutic capabilities and novel exosome-based predictive tools for head and neck cancer.»

About Aethlon Medical, Inc. and the Hemopurifier®

Aethlon Medical, Inc. is focused on addressing unmet needs in global health. The Aethlon Hemopurifier is a clinical-stage device designed to combat cancer and life-threatening viral infections.

In preclinical studies in cancer, the Hemopurifier depletes the presence of circulating tumor-derived exosomes that are believed to promote immune suppression. These tumor derived exosomes also appear to seed the spread of metastases and therefore may inhibit the benefit of leading cancer therapies. The Hemopurifier® is an FDA designated «Breakthrough Device» related to the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease cancer.  The FDA has approved an Investigational Device Exemption (IDE) application to initiate an Early Feasibility Study (EFS) of the Hemopurifier® in patients with head and neck cancer in combination with standard of care pembrolizumab (Keytruda).  The Hemopurifier also is an FDA designated «Breakthrough Device» related to life-threatening viruses that are not addressed with approved therapies. The FDA also has approved a supplement to the Company’s existing IDE to allow for the testing of the Hemopurifier® in patients with SARS-CoV-2/COVID-19 in a new feasibility study.

Aethlon also owns 80% of Exosome Sciences, Inc., which is focused on the discovery of exosomal biomarkers to diagnose and monitor cancer and neurological disease progression. Additional information can be found online at www.AethlonMedical.com and www.ExosomeSciences.com.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that involve risks and uncertainties. Statements containing words such as «may,» «believe,» «anticipate,» «expect,» «intend,» «plan,» «project,» «will,» «projections,» «estimate,» «potentially,» «appear» or similar expressions constitute forward-looking statements. Such forward-looking statements are subject to significant risks and uncertainties and actual results may differ materially from the results anticipated in the forward-looking statements. Factors that may contribute to such differences include, without limitation, Aethlon Medical, Inc.’s (the Company) ability to successfully complete the grant for studies in head and neck cancer with the UPMC Hillman Cancer Center at the University of Pittsburgh, or to successfully complete the Early Feasibility Studies in head and neck cancer or in COVID-19, Aethlon’s ability to demonstrate that the removal of exosomes with the Hemopurifier will result in better outcomes for the treatment of cancer, and Aethlon’s ability to successfully develop and commercialize the Hemopurifier, its ability to raise additional funds and other risks. The foregoing list of risks and uncertainties is illustrative, but is not exhaustive. Additional factors that could cause results to differ materially from those anticipated in forward-looking statements can be found under the caption «Risk Factors» in the Company’s Annual Report on Form 10-K for the year ended March 31, 2019, and in the Company’s other filings with the Securities and Exchange Commission, including its quarterly Reports on Form 10-Q. Except as may be required by law, the Company does not intend, nor does it undertake any duty, to update this information to reflect future events or circumstances.

Company Contact:
Jim Frakes
Chief Financial Officer
Aethlon Medical, Inc. 
858-459-7800 x3300
Jfrakes@aethlonmedical.com

Media Contact:
Tony Russo, Ph.D.
Russo Partners, LLC
tony.russo@russopartnersllc.com
212-845-4251

Investor Contact:
Susan Noonan
S.A. Noonan Communications, LLC
susan@sanoonan.com 
212-966-3650

 

Cision View original content:http://www.prnewswire.com/news-releases/aethlon-medical-announces-collaboration-with-university-of-pittsburgh-on-nih-grant-for-head-and-neck-cancer-301106689.html

SOURCE Aethlon Medical, Inc.

CFI Realizes Immediate and Ongoing Safety Improvement After Installing SmartDrive Video-Based Safety Program

SAN DIEGO, Aug. 6, 2020 /PRNewswire/ —

SAN DIEGO, Aug. 6, 2020 /PRNewswire/ — SmartDrive Systems, a leader in video-based safety and transportation intelligence, announced today that CFI, a North American full-truckload carrier and operating company of TFI International Inc., has reported significant improvements in safety outcomes, including multiple driver exonerations and a reduction in DOT accident frequency, after 18 months with the SmartDrive program.

«CFI is committed to our core value of safety,» commented Jeff Yarnall, director of safety at CFI. «Our fleet is always looking for opportunities to do better and that’s when we turned to video. It was the next step in the evolution of our safety program. After evaluating five companies, we found SmartDrive offered the best product for our specific needs at CFI.»

Initially, CFI planned to test the SmartDrive program in 500 vehicles. After discovering video-based safety’s positive impact on culture and the bottom line, the CFI leadership team rolled the program out to the entire fleet of 2,000 vehicles.

«We were looking for a program that was going to help us coach to safe driving techniques by providing actionable information that could be leveraged at any level within our organization,» said Yarnall. «SmartDrive helped us to quickly identify the leading indicators that lead to unsafe behavior, and this allows us to intervene and reduce collisions. We had acceptance across the fleet when we began the program and, since complete installation, some of our original challenges have turned into success stories.»

During a 12-month period, CFI reported a 73% improvement in its SmartDrive Safety Score, an objective measurement of specific driving habits including speeding, seat belt usage, distracted driving and other habits that increase the likelihood of collisions. Since adopting the SmartDrive program, the fleet has reported a decrease in its preventable DOT accident frequency, a reduction in the total number of accidents, and a drop in the cost per accident.

«By adopting a video-based safety program and effectively introducing the technology to fleet managers and drivers, CFI immediately saw results in terms of collisions and risky behavior,» said Steve Mitgang, CEO of SmartDrive. «We are excited to see that, like many other fleets that have implemented the program, CFI has continued to experience improvement in individual driver performance through effective driver coaching and video recordings.»

About CFI

CFI, a wholly owned operating company of TFI International Inc., is a multifaceted leading transportation provider. Established in 1951, the truckload segment delivers time-definite 53-foot dry-van truckload transportation services. Operations in Mexico add an owned LTL network to the portfolio. CFI offers global logistics solutions to support all modes of transportation including ground transport, air freight, warehousing and intermodal with North American cross-border expertise and bilingual support. TFI International Inc. is a North American leader in the transportation and logistics industry, operating across the United States, Canada and Mexico through its subsidiaries.

TFI International Inc. is publicly traded on the New York Stock Exchange and the Toronto Stock Exchange under the symbol TFII. For more information, visit www.tfiintl.com.

About SmartDrive Systems

SmartDrive Systems gives fleets and drivers unprecedented driving performance insight and analysis, helping save fuel, expenses and lives. Its video safety, predictive analytics, telematics, compliance and personalized performance program help fleets improve driving skills, lower operating costs and deliver significant ROI. With an easy-to-use managed service, fleets and drivers can access and self-manage driving performance anytime, anywhere. The company, which is ranked as one of the fastest growing companies by Deloitte’s Technology Fast 500™ for six consecutive years, has recorded over 15 billion miles and compiled the world’s largest storehouse of more than 300 million analyzed risky-driving events. SmartDrive Systems is based in San Diego, Calif., and employs over 725 people worldwide.

For more information on SmartDrive Systems, please visit www.smartdrive.net.

Contact or Follow SmartDrive on:
Email – tryuson@smartdrive.net
Facebook – http://www.facebook.com/smartdrivesystemsinc
Twitter – http://www.twitter.com/smartdriveinc
YouTube – http://www.youtube.com/smartdrivesystemsinc
LinkedIn – http://www.linkedin.com/company/smartdrive-systems

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cfi-realizes-immediate-and-ongoing-safety-improvement-after-installing-smartdrive-video-based-safety-program-301107378.html

SOURCE SmartDrive Systems

Michigan’s Sports Betting and Online Gambling To Bring $650M In First-Year Revenue, According to MichiganSharp.com

DETROIT, Aug. 6, 2020 /PRNewswire/ — Sports betting and online casinos could produce as much as $93 million in first-year tax revenue in Michigan, according to projections from MichiganSharp.com.

The first of

DETROIT, Aug. 6, 2020 /PRNewswire/ — Sports betting and online casinos could produce as much as $93 million in first-year tax revenue in Michigan, according to projections from MichiganSharp.com.

The first of Michigans online sports betting and casino platforms might launch by the end of 2020. This sets the stage for Michigan to become one of the top online gambling states in the U.S.

Competitive State Tax Rates Make for an Online Betting Hub

Gross revenue from sports betting, both online and retail, will be taxed at 8.4% from the state. Detroits three commercial casinos pay an additional 1.25% city tax.

Michigan hosts 26 land-based casinos, all of which can be expected to offer sports betting and online gaming to the states 10-million population at some point.

«All of the pieces are in place for Michigan to become a major hub for sports betting and online gambling,» said Geoff Fisk, analyst for MichiganSharp.com. «Virtually all of the states casinos should want a piece of the new market, especially with the attractive tax rates.»

By comparison, New Jersey taxes land-based sports betting at 9.75% and online sportsbooks at 13%. Indianas online sports betting tax is levied at 9.5%, while Pennsylvania taxes sports betting at 36%.

State lawmakers passed House Bill 4916 in December 2019, which legalized both retail and online sports betting. The bill also brings online casinos and online poker to the state, setting the stage for Michigan to become one of the biggest legal online gambling markets in the US.

All 26 of Michigans retail casinos can apply for sports betting and internet gaming licenses through the Michigan Gaming Control Board. In a situation unique to Michigan, the states three commercial casinos, as well as the 23 tribal casinos, are eligible to offer internet gaming.

Online sports betting has proven massively successful in Pennsylvania and New Jersey. In both states, online wagering accounts for more than 80 percent of total sports betting revenue.

First-Year Revenue Projections of $650M, According to MichiganSharp.com

MichiganSharp.com projects that the state could bring in as much as $400 million in total first-year sports betting revenue, producing $33.6 million in tax revenue for the state.

«Mobile wagering should be the major revenue driver for Michigans sports betting market,» Fisk said. «The convenience and ease of access of online sports betting opens up a whole new world of opportunities for both bettors and sportsbook operators.»

Online casino and poker revenue will be taxed at 20-28% from the state, using a tier system dependent on earnings. MichiganSharp.com projects that online casinos and poker could earn as much as $250 million in first-year operations, bringing in a possible $60 million in tax revenue.

MichiganSharp.com projects that total revenue from sports betting, online casinos, and online poker, could earn $650 million in year one of operations, resulting in $93.6 million in tax revenue for the state.

For more analysis and news on the latest developments in Michigans legal gambling industry, visit MichiganSharp.com.

Contact: Amber Hoffman, Managing Editor of MichiganSharp.com: amber.hoffman@i15Media.com 

Cision View original content:http://www.prnewswire.com/news-releases/michigans-sports-betting-and-online-gambling-to-bring-650m-in-first-year-revenue-according-to-michigansharpcom-301107177.html

SOURCE MichiganSharp.com

Egan Law Launches «Walk In» Family Law and Immigration Clinic (FLIC)

SANTA MARIA, Calif., Aug. 6, 2020 /PRNewswire/ — Egan Law today announced the opening of FLIC (Family Law & Immigration Center).  FLIC’s Executive Director and Supervising Attorney M. Jude Egan reports that the center is providing a new model of legal assistance services to those who otherwise may not be able to afford to hire full-service legal assistance or pay retainer fees, or who choose to assert more control over their legal fees and costs. «The need for…

SANTA MARIA, Calif., Aug. 6, 2020 /PRNewswire/ — Egan Law today announced the opening of FLIC (Family Law & Immigration Center).  FLIC’s Executive Director and Supervising Attorney M. Jude Egan reports that the center is providing a new model of legal assistance services to those who otherwise may not be able to afford to hire full-service legal assistance or pay retainer fees, or who choose to assert more control over their legal fees and costs. «The need for this center stemmed from the lack of lower-cost legal resources in the areas of family and immigration law. Existing legal aid clinics are often limited by their mandates to only serve people under a certain income threshold or with defined immigration status and are, in any event, limited by available staffing resources,» said Egan.  

According to the 2010 US census, 64% of households in Santa Maria speak a language other than English and 62% of households subsist within 125% of the poverty line. Additionally, approximately 65% of family law parties are representing themselves in the family court, while data from the American Immigration Council indicates that only 37% of immigrants in removal cases had counsel nationwide, with the number far lower for Central American immigrants. 

Egan, who is also a Certified Family Law Specialist certified by the State Bar of California, adds that because «FLIC operates on a clinic or doctor’s office model, it is not subject to government limitations on whom it can serve.  All are welcome without regard to income or immigration status.  An attorney counsels the client, sets forth strategy and advises the client and assigns staff members to draft and submit documents to the Courts or the consulate.»  

FLIC’s access-to-a-lawyer-at-any-time model distinguishes it from Legal Document Assistant and self-help legal services, who can help with legal forms, but are not permitted to dispense legal advice under state law. «While there is a place for Legal Document Assistants in poor communities, they are often pushed to inappropriately dispense legal advice. I’ve seen this ‘advice’ cost parties tens of thousands of dollars and even cause them to lose their case so many times. Just a 30-minute meeting with a lawyer could have avoided sometimes tragic results,» said Egan. «We are not trying to take aim at LDAs or self-help legal providers, per se, but FLIC can provide accurate legal advice and deliver paperwork on a timely basis for the same or less than the cost of a non-lawyer, leaving clients with the possibility of full-service engagement if they decide to go that route and access to counsel at any time for a fraction of the cost of full-service representation.»

Elizabeth Ramirez Barragan, an immigration attorney who also handles family law matters and FLIC’s Assistant Director and Staff Attorney says, «One of the biggest challenges of working with full-service law firms is that the lawyer and the client often do not know exactly how much a legal action is going to cost. We help anyone, from those trying to control their legal costs to those who need legal help but can’t afford to hire a lawyer to do it all for them; and they know exactly how much it will cost them before the work is done.»  Furthermore, Ramirez explains, «FLIC lets clients pick and choose the legal services they get from a menu of options each with a set price, from simple consultations and drafting documents to full-service representation. All of this is done so that almost anyone can afford to hire a lawyer to advise them throughout their case» 

ABOUT FLIC: FLIC provides legal advice, helps draft divorce, custody and child and spousal support motions and declarations, fee waiver applications and financial disclosures. Our team will fill out proper forms under direction from lawyers, and provide advice on how to handle a case in court, including how to fix problem cases.  For immigration, we will assist you with all aspects of immigration law from DREAM Act filings to visa applications. Attorneys may also make limited scope appearances for clients, by mutual agreement, on a case by case basis.  

FLIC attorneys and staff are meeting with clients via Zoom. We are licensed across the State of California and can assist people in matters across the State. 

For more information, visit www.fliconline.us

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/egan-law-launches-walk-in-family-law-and-immigration-clinic-flic-301107323.html

SOURCE FLIC – Attorney M. Jude Egan

Qintess Announces An Investment Of Ten Million BRL Towards Programs Fostering Entrepreneurship, Diversity And Social Innovation In Brazil

SÃO PAULO, Aug. 6, 2020 /PRNewswire/ — QINTESS, one of the top ten major IT companies in Brazil, announces an investment of R$ 10 million over the next five years to support and foster entrepreneurship, diversity, and social innovation in Brazil. Vale do Dendê, an entrepreneurial innovation center based in the city of Salvador, will be the first organization to receive funding. Resources for training and…

SÃO PAULO, Aug. 6, 2020 /PRNewswire/ — QINTESS, one of the top ten major IT companies in Brazil, announces an investment of R$ 10 million over the next five years to support and foster entrepreneurship, diversity, and social innovation in Brazil. Vale do Dendê, an entrepreneurial innovation center based in the city of Salvador, will be the first organization to receive funding. Resources for training and seed capital will be provided to young Afro-descendant-led startups and businesses focused on cultivating diversity and creating growth in this area.

This national initiative, spearheaded by Qintess, seeks to increase the number of entrepreneurs in the tech industry who are of African descent, who are from the LGBTI+ community and who are disabled, as well as from other marginalized communities. It also seeks to help small businesses make the transition to digital in order to remain viable during and after the Coronavirus pandemic. Collaborative businesses, gaming companies and digital startups will be supported with training, with global and national mentorship, as well as with access to seed capital.

Qintess has selected Vale do Dendê as their strategic partner in the social business space because of their successful track record with regard to organizing and supporting entrepreneurs from marginalized communities. They are one of Brazil’s leaders among businesses focused on social impact. Vale do Dendê focuses on the Northeast of Brazil, one of the regions currently in the most need of investment. Furthermore, this partnership will result in the establishment of new innovation hubs mirroring the ones currently in place at Vale do Dendê. These will exist in every capital where Qintess is located, including São Paulo, Rio de Janeiro, Belo Horizonte, Porto Alegre, Curitiba and Fortaleza.

As part of this strategic partnership, Qintess will be sponsoring Vale do Dendê to ensure that the organizational culture and vision created by its founders is cultivated and given the opportunity to grow and expand. «This initiative is coherent with my philosophy. It is fundamental for the companies to develop and implement concrete actions instead of only talking about diversity and inclusion», says Nana Baffour, CEO, Chairman and Culture Chief Officer of Qintess.

Qintess’ aims to have 2,000 young people from marginalized communities virtually trained in coding (Java, .Net, and Python) within the next five years. The company also looks to accelerate 500 companies by leveraging professional mentors with great market experience as well as their relationships with investors. Fifty of these companies will have access to Qintess’ company fund of R $2.5 million as seed capital to scale their businesses.

According to Lauro Chacon, Vice-President of Qintess Human Capital, this initiative meets the company’s strategies in considering ESG practices in order to promote sustainable growth. «We are an organization oriented to people and we use best environmental, social and corporate governance practices to guide our business. When establishing a partnership such as this one, it is important to reinforce our commitment to promoting diversity, to speeding up innovation and to contributing to all of our clients, collaborators and stakeholder ecosystems, as well as to society as a whole.», he says.

Qintess’ executives and its team of collaborators will bring new digital technologies and management techniques to increase Vale do Dendê’s scalability. Valde do Dendê has been operating an acceleration program since 2018. This initiative, which operated out of a physical hub inside one of the biggest bus and subway stations in Salvador, has already benefitted 90 startup companies.

«It is a moment of celebration and pride! I have no doubts that all of the legacy built by Vale do Dendê for Salvador and Brazil’s ecosystem will be strengthened by this partnership.», says Ítala Herta, Vale do Dendê’s co-founder.

«This partnership with Qintess confirms our bet on the importance of Salvador’s outskirts in particular, and of the Northeast in general, in the development of a creative economy and of innovation in Brazil. I believe the country will not fulfill its destiny of being a great nation if it is not capable of integrating young Afro-Brazilians into sustainable development», says Rosenildo Ferreira, co-founder and Innovation and Marketing Director of Vale do Dendê. 

«We are very happy to be entering in this agreement with Qintess. We believe that because Qintess is a great technology company with great investment capacity, it can support our dream and allow it to thrive for many years, expanding on the work we have started,» says Paulo Rogério Nunes, co-founder and Executive Director of Vale do Dendê.

Teams involving Qintess’ and Vale do Dendê’s executives and collaborators are beginning their joint activities this month. The plan is to implement more than one round of acceleration and of training courses in the technology sector for young people, which will be in operation until the end of the year.

According to Roberto Silva, Qintess Regional Director for The Northeast and Minas Gerais, that partnership makes Vale do Dendê the protagonist in digital transformation for the region. «We are very proud of this partnership because we are going to bring together social entrepreneurship and cutting-edge technology to promote responsible practices.»

Cision View original content:http://www.prnewswire.com/news-releases/qintess-announces-an-investment-of-ten-million-brl-towards-programs-fostering-entrepreneurship-diversity-and-social-innovation-in-brazil-301107228.html

SOURCE Qintess

Cape Cod Project Brings Innovation to Long-Term Care

BOURNE, Mass., Aug. 6, 2020 /PRNewswire/ — Canal Street Crossing – a private, fully permitted residential and health care development in Bourne, Massachusetts – is bringing an innovative model for long-term care to Massachusetts seniors, just…

BOURNE, Mass., Aug. 6, 2020 /PRNewswire/ — Canal Street Crossing – a private, fully permitted residential and health care development in Bourne, Massachusetts – is bringing an innovative model for long-term care to Massachusetts seniors, just as the impact of COVID-19 on this population is being fully realized.

In the US, 40% of all COVID-19 fatalities have been associated with long-term care facilities and nursing homes. In Massachusetts COVID-19 related deaths in nursing homes and long-term care facilities account for 62% of the state’s total. More than 80 long term care facilities in Massachusetts reported at least 20 resident deaths and five homes recorded more than 50 deaths each.

«We’re building a development which we believe will become a new standard for long-term care for our senior and disabled populations, one that may prevent recurrence of the tragedy we are currently witnessing,» said Bob Gendron, CEO and President of GenReal, Inc., which owns the projects.

Gendron, a Cape Cod native and a global leader in facilities management, cited the current physical environment of care in nursing homes as having a significant impact in the high infection and fatality rates. Often rooms are occupied by four residents and conventional nursing home wings can house as many as 40 residents. The common areas promote intermingling of populations sick and healthy. Medical attention is focused on immediate physical symptoms and not long-term health care management.

Canal Street Crossing takes a more innovative approach to design and management, using the nationally recognized Green House Project Model, developed in conjunction with the Robert Wood Johnson Foundation. Under this model, each elder has a private room and bathroom suite, and also encourages social interaction by bringing together 10-14 elders in homelike settings with shared space. The private suites are wired with rapid response telehealth technology and Certified Nursing Assistants manage each home on a 24/7 basis.

«As the vision came together for this project, our team knew that we needed to bring ideas at the forefront of design and care together to meet the challenges being face by our seniors,» said Gendron. «By bringing together key services, an innovative model and state-of-the art architectural design, we’ll be able to keep seniors safer and improve their overall quality of life.»

The Canal Street Crossing campus will contain 30 independent living units, 48 supportive assisted living units, 28 skilled nursing home beds and 14 memory care beds. A health care facility will be located on the campus, consisting of medical and diagnostic services as well as a full range of health care services.

GenReal, Inc., will own the project. The supportive assisted living, skilled nursing care beds and the memory unit beds will be managed by Navigator Elder Homes. A program for older adults, known as PACE, will be integrated on the campus and owned and administered by Harbor Health Services, Inc.

CONTACT:
Patrick Murphy
617-898-7985
pmurphy@cref.com

 

Cision View original content:http://www.prnewswire.com/news-releases/cape-cod-project-brings-innovation-to-long-term-care-301107317.html

SOURCE Canal Street Crossing

BTL files complaint with the U.S. International Trade Commission to seek an exclusion order to prevent the unlawful importation of infringing Cooltone and Coolsculpting products into the United States

MARLBOROUGH, Mass., Aug. 6, 2020 /PRNewswire/ — BTL Industries, Inc. («BTL»), the leading manufacturer of the EMSCULPT body-contouring device and other products for non-invasive body-shaping procedures, filed a complaint today with the United States International Trade Commission («ITC»), asking the Commission to prevent Allergan Limited, Allergan, Inc., Allergan USA Inc., Zeltiq Aesthetics, Inc., Zeltiq Ireland Unlimited Company («Allergan»), and Zimmer…

MARLBOROUGH, Mass., Aug. 6, 2020 /PRNewswire/ — BTL Industries, Inc. («BTL»), the leading manufacturer of the EMSCULPT body-contouring device and other products for non-invasive body-shaping procedures, filed a complaint today with the United States International Trade Commission («ITC»), asking the Commission to prevent Allergan Limited, Allergan, Inc., Allergan USA Inc., Zeltiq Aesthetics, Inc., Zeltiq Ireland Unlimited Company («Allergan»), and Zimmer MedizinSysteme GmbH, Germany («Zimmer») from importing products that infringe BTL’s patents into the United States. BTL concurrently filed a lawsuit with the U.S. Federal District Court in the District of Delaware against Allergan and Zimmer on the same matter.

The U.S. International Trade Commission is an independent, quasi-judicial federal agency with broad investigative responsibilities on matters that affect trade and commerce, including intellectual property infringement.

«We have asked the ITC to determine whether Cooltone and Coolsculpting products infringe BTL’s patents and, if they are found to be infringing, to issue an exclusion order barring importation of Cooltone and Coolsculpting products into the U.S., as well as issuing a cease-and-desist order prohibiting Allergan and Zimmer from selling their infringing products and their components in the American market space,» said Ron Borsheim, VP of Business Development.

BTL’s ITC complaint and Delaware lawsuit follows a lawsuit that BTL filed with the U.S. District Court in Delaware in December 2019 on similar matters.

About BTL Group:
Founded in 1993, BTL Group has grown to become an innovator and world leader in non-invasive products and treatments for the aesthetics and physiotherapy industries. With over 2,000 employees in more than 53 countries, BTL offers the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments, including treatment of incontinence. BTL’s brands include EMSCULPT, EMSELLA, EXILIS, and EMTONE.

About Emsculpt:
BTL’s Emsculpt has been a clear innovation leader in the muscle category, revolutionizing the non-invasive body shaping market. Utilizing its proprietary high intensity focused electromagnetic energy (HIFEM®), the Emsculpt introduced an entirely new category of muscle toning and muscle strengthening to the aesthetic industry that goes beyond waistline reduction and elimination of fat cells. For more details, go to www.emsculpt.com.

 

(PRNewsfoto/BTL)

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/btl-files-complaint-with-the-us-international-trade-commission-to-seek-an-exclusion-order-to-prevent-the-unlawful-importation-of-infringing-cooltone-and-coolsculpting-products-into-the-united-states-301107304.html

SOURCE BTL

Mopec Now Offering Ready-to-Ship Personal Protective Equipment (PPE)

MADISON HEIGHTS, Mich., Aug. 6, 2020 /PRNewswire/ — Mopec—a leading provider of high-quality pathology, anatomy, mortuary, and necropsy equipment and products—is now offering

MADISON HEIGHTS, Mich., Aug. 6, 2020 /PRNewswire/ — Mopec—a leading provider of high-quality pathology, anatomy, mortuary, and necropsy equipment and products—is now offering personal protective equipment (PPE). The in-stock and ready-to-ship PPE offering includes FDA- and CE-compliant products such as full-length face shields, 3-ply and KN95 masks, no-contact infrared thermometers and hand sanitizer.

The PPE products are the latest addition to the Mopec product line in response to the ongoing COVID-19 crisis.

«It is crucial we continue to prioritize the health and safety of workers in the health care industry, as well as those working in medical examiners offices and funeral homes,» said Jay Troger, CEO of Mopec. «We’re continuing to draw on our experience and relationships in the industry to address the increasing demands of our customers and help ensure they have the products they need.»

Mopec’s PPE offerings are just one aspect of the company’s Guardian Systems line of COVID-19 Preparation and Response products. The company currently offers:

  • MAXAIR – The most innovative and easy-to-use powered air-purifying respirator available, the MAXAIR CAPR series requires no-fit testing and no N95 masks.
  • Guardian Rack System – Designed and engineered to meet the needs of morgues during mass fatality events and surges, the Guardian Rack can be quickly assembled and deployed to provide additional remains storage capacity.
  • MERC System – This direct-contact cooling system utilizes liquid cooling technology to store human remains and is the only system that is completely portable, scalable and interoperable.
  • Body Bags – Mopec is currently offering nine varieties of body bags, produced in the United States and available for immediate shipment.

Since the start of the pandemic, the company has distributed products and equipment in more than 30 states and in Puerto Rico to customers from some of the nation’s top hospital and health care systems as well as state and government organizations.

Learn more about available products at Mopec.com.

About Mopec

Mopec, based in Madison Heights, Michigan, is a manufacturer and distributor of high-quality pathology, anatomy, mortuary, and necropsy equipment and products. Founded in 1992, Mopec differentiates itself through its extensive engineering process, superior design, and market-leading quality. Mopec is Better By Design and specializes in solutions for hospitals, universities, morgues, and a variety of other markets. Mopec is committed to the production innovative products and providing high quality customer service. For more information, visit www.mopec.com.

About Blackford Capital

Blackford Capital is a private equity firm based in Grand Rapids, Michigan, that acquires, manages and builds family-owned, lower middle-market manufacturing, distribution, and service companies. Blackford currently has 11 portfolio companies located across the United States and has been recognized as one of America’s fastest growing private companies by Inc. 5000 in 2016 and 2017. For more information, visit www.blackfordcapital.com.

MEDIA CONTACT:
Lisa Lark
313.410.8477
llark@lambert.com

 

Cision View original content:http://www.prnewswire.com/news-releases/mopec-now-offering-ready-to-ship-personal-protective-equipment-ppe-301107522.html

SOURCE Mopec